National Cancer Institute (NCI) implementation of the American Society of Clinical Oncology (ASCO) and Friends of Cancer Research (Friends) broadening clinical trials eligibility criteria.

被引：2
|
作者：
Denicoff, Andrea M.
Ivy, S. Percy
Worthington, Katherine H.
Zhao, Jinxiu
Seibel, Nita
Mishkin, Grace E.
Mooney, Margaret M.
Little, Richard F.
机构：
[1] NCI, Rockville, MD USA
[2] Emmes Co LLC, Rockville, MD USA
[3] NCI, Bethesda, MD USA
[4] NCI, Canc Therapy Evaluat, Bethesda, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.6518
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6518
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement
    Kim, Edward S.
    Bruinooge, Suanna S.
    Roberts, Samantha
    Ison, Gwynn
    Lin, Nancy U.
    Gore, Lia
    Uldrick, Thomas S.
    Lichtman, Stuart M.
    Roach, Nancy
    Beaver, Julia A.
    Sridhara, Rajeshwari
    Hesketh, Paul J.
    Denicoff, Andrea M.
    Garrett-Mayer, Elizabeth
    Rubin, Eric
    Multani, Pratik
    Prowell, Tatiana M.
    Schenkel, Caroline
    Kozak, Marina
    Allen, Jeff
    Sigal, Ellen
    Schilsky, Richard L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (33) : 3737 - 3744
  • [2] Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research HIV Working Group
    Uldrick, Thomas S.
    Ison, Gwynn
    Rudek, Michelle A.
    Noy, Ariela
    Schwartz, Karl
    Bruinooge, Suanna
    Schenkel, Caroline
    Miller, Barry
    Dunleavy, Kieron
    Wang, Judy
    Zeldis, Jerome
    Little, Richard F.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (33) : 3774 - 3780
  • [3] Examining Exclusion Criteria in Advanced Prostate Cancer Clinical Trials: An Assessment of recommendations From the American Society Of Clinical Oncology and Friends of Cancer Research
    Ebrahimi, Hedyeh
    Castro, Daniela V.
    Feng, Matthew I.
    Prajapati, Sweta R.
    Lee, Kyle O.
    Chan, Elyse H.
    Paul, Trishita
    Sehgal, Ishaan
    Patel, Jalen
    Li, Xiaochan
    Zengin, Zeynep B.
    Meza, Luis
    Mercier, Benjamin D.
    Hsu, Joann
    Govindarajan, Ameish
    Chawla, Neal
    Dizman, Nazli
    Bergerot, Cristiane D.
    Rock, Adam
    Liu, Sandy
    Tripathi, Abhishek
    Dorff, Tanya
    Pal, Sumanta K.
    Chehrazi-Raffle, Alexander
    CLINICAL GENITOURINARY CANCER, 2023, 21 (06) : e467 - e473
  • [4] Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Brain Metastases Working Group
    Lin, Nancy U.
    Prowell, Tatiana
    Tan, Antoinette R.
    Kozak, Marina
    Rosen, Oliver
    Amiri-Kordestani, Laleh
    White, Julia
    Sul, Joohee
    Perkins, Louise
    Beal, Katherine
    Gaynor, Richard
    Kim, Edward S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (33) : 3760 - 3773
  • [5] Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO-Friends of Cancer Research Joint Research Statement
    Kim, Edward S.
    Uldrick, Thomas S.
    Schenkel, Caroline
    Bruinooge, Suanna S.
    Harvey, R. Donald
    Magnuson, Allison
    Spira, Alexander
    Wade, James L.
    Stewart, Mark D.
    Vega, Diana Merino
    Beaver, Julia A.
    Denicoff, Andrea M.
    Ison, Gwynn
    Ivy, S. Percy
    George, Suzanne
    Perez, Raymond P.
    Spears, Patricia A.
    Tap, William D.
    Schilsky, Richard L.
    CLINICAL CANCER RESEARCH, 2021, 27 (09) : 2394 - 2399
  • [6] Modernizing Clinical Trial Eligibility: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Minimum Age Working Group
    Gore, Lia
    Ivy, S. Percy
    Balis, Frank M.
    Rubin, Eric
    Thornton, Katherine
    Donoghue, Martha
    Roberts, Samantha
    Bruinooge, Suanna
    Ersek, Jennifer
    Goodman, Nancy
    Schenkel, Caroline
    Reaman, Gregory
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (33) : 3781 - 3787
  • [7] Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Prior Therapies Work Group
    Osarogiagbon, Raymond U.
    Vega, Diana Merino
    Fashoyin-Aje, Lola
    Wedam, Suparna
    Ison, Gwynn
    Atienza, Sol
    De Porre, Peter
    Biswas, Tithi
    Holloway, Jamie N.
    Hong, David S.
    Wempe, Madison M.
    Schilsky, Richard L.
    Kim, Edward S.
    Wade, James L., III
    CLINICAL CANCER RESEARCH, 2021, 27 (09) : 2408 - 2415
  • [8] Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group
    Magnuson, Allison
    Bruinooge, Suanna S.
    Singh, Harpreet
    Wilner, Keith D.
    Jalal, Shadia
    Lichtman, Stuart M.
    Kluetz, Paul G.
    Lyman, Gary H.
    Klepin, Heidi D.
    Fleury, Mark E.
    Hirsch, Brad
    Melemed, Allen
    Arnaldez, Fernanda, I
    Roy, Upal Basu
    Schenkel, Caroline
    Sherwood, Shimere
    Garrett-Mayer, Elizabeth
    CLINICAL CANCER RESEARCH, 2021, 27 (09) : 2424 - 2429
  • [9] Growth in eligibility criteria content and failure to accrue among National Cancer Institute (NCI)-affiliated clinical trials
    Peterson, John S.
    Plana, Deborah
    Bitterman, Danielle S.
    Johnson, Skyler Bryce
    Aerts, Hugo J. W. L.
    Kann, Benjamin Harris
    CANCER MEDICINE, 2023, 12 (04): : 4715 - 4724
  • [10] Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Organ Dysfunction, Prior or Concurrent Malignancy, and Comorbidities Working Group
    Lichtman, Stuart M.
    Harvey, R. Donald
    Smit, Marie-Anne Damiette
    Rahman, Atiqur
    Thompson, Michael A.
    Roach, Nancy
    Schenkel, Caroline
    Bruinooge, Suanna S.
    Cortazar, Patricia
    Walker, Dana
    Fehrenbacher, Louis
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (33) : 3753 - 3759
12345